0
Editorials: Point and Counterpoint |

COUNTERPOINT: Do the Benefits Outweigh the Risks for Most Patients Under Consideration for Inferior Vena Cava Filters? No

Mark L. Lessne, MD; Ronald F. Sing, DO, FCCP
Author and Funding Information

FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: R. F. S. has received educational grant support from CR Bard, Cook Medical, Volcano Medical, and Argon Medical. None declared (M. L. L.).

aVascular and Interventional Specialists of Charlotte Radiology, Carolinas HealthCare System, Charlotte, NC

bDepartment of Trauma Surgery, Carolinas HealthCare System, Charlotte, NC

CORRESPONDENCE TO: Mark L. Lessne, MD, 1701 East Blvd, Charlotte, NC 28203


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;150(6):1182-1184. doi:10.1016/j.chest.2016.08.1477
Text Size: A A A
Published online

Extract

Since the Mobin-Uddin umbrella launched in the late 1960s, the implantation of inferior vena cava (IVC) filters has vastly outpaced the quality evidence for their use. In 2012, approximately 250,000 IVC filters were placed in the United States, representing nearly a 1,300-fold increase in 30 years and 25 times the number that were placed in five European countries with comparable total population size.,,,,,, However, despite these staggering volumes, and contrary to expectation, the number of deaths related to venous thromboembolic events (VTEs) in equivalent population sizes were similar in the United States and Europe. We are left asking: what explains the United States’ obsession with IVC filters?

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543